The U.S. Centers for Disease Control and Prevention advisory panel could vote on the use of a third shot of Pfizer-BioNTech's COVID-19 vaccine on Thursday, an agency official said while kicking off the two-day panel discussion on Wednesday.
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on Thursday
Post a Comment